Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DMAA Is Synthetic And Needs NDI Notification – Study

This article was originally published in The Tan Sheet

Executive Summary

Botanical experts refute that DMAA is a geranium plant derivative and that the ingredient has been common in the food supply, as some supplement manufacturers have argued. “Elementary mathematics establishes that [DMAA] in dietary supplements must be synthetic,” study authors say.

You may also be interested in...



Dendrobium, PEA Supplements Carry Risks For Manufacturers

FDA warns against using dendrobium and phenethylamines in dietary supplements, but firms that move forward anyways should do so “with eyes wide open” and conduct extra identity, safety and quality assurance tests, CRN’s MacKay advises.

Dendrobium, PEA Supplements Carry Risks For Manufacturers

FDA warns against using dendrobium and phenethylamines in dietary supplements, but firms that move forward anyways should do so “with eyes wide open” and conduct extra identity, safety and quality assurance tests, CRN’s MacKay advises.

Labels Offer FDA Clues To Spiked Supplements, Health Fraud

Claims that promise too much point FDA to products marketed as supplements that warrant investigation for health fraud, CFSAN’s Corey Hilmas tells USP workshop on economically motivated adulteration.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS105825

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel